Dampening HOTAIR sensitizes the gastric cancer cells to oxaliplatin through miR-195-5p and ABCG2 pathway
- PMID: 37621132
- PMCID: PMC10660622
- DOI: 10.1111/jcmm.17925
Dampening HOTAIR sensitizes the gastric cancer cells to oxaliplatin through miR-195-5p and ABCG2 pathway
Abstract
Long non-coding RNAs (lncRNA) have an extensive role in the progression and chemoresistance of gastric cancer (GC). Deeply study the regulatory role of lncRNAs could provide potential therapeutic targets. The aim of this study is to explore the regulatory role of HOTAIR in the progression and oxaliplatin resistance of GC. The expression of HOTAIR in GC and cell lines were detected by using qRT-PCR. Cell proliferation and apoptosis were analysed by CCK-8, EdU incorporation and flow cytometry. Luciferase reporter assay was used to identify the interaction between HOTAIR and ABCG2 (ATP-binding cassette (ABC) superfamily G member 2, ABCG2) via miR-195-5p. The regulatory functions were verified by using molecular biology experiments. HOTAIR was significantly overexpressed in GC and associated with poor prognosis. Knock-down of HOTAIR inhibited the GC cells proliferation and oxaliplatin resistance, while overexpression of HOTAIR showed opposite functions. Further studies found that HOTAIR acted as a competing endogenous RNA (ceRNA) to absorb miR-195-5p and elevated the expression of ABCG2, which leads to resistance of GC cells to oxaliplatin. Taken together, our findings demonstrated that HOTAIR regulates ABCG2 induced resistance of GC to oxaliplatin through miR-195-5p signalling and illustrate the great potential of developing new therapeutic targets for GC patients.
Keywords: ABCG2; HOTAIR; chemoresistance; gastric cancer.
© 2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









Similar articles
-
Long non-coding RNA Hotair promotes gastric cancer progression via miR-217-GPC5 axis.Life Sci. 2019 Jan 15;217:271-282. doi: 10.1016/j.lfs.2018.12.024. Epub 2018 Dec 14. Life Sci. 2019. PMID: 30557546
-
MicroRNA-328 acts as an anti-oncogene by targeting ABCG2 in gastric carcinoma.Eur Rev Med Pharmacol Sci. 2019 Jul;23(14):6148-6159. doi: 10.26355/eurrev_201907_18428. Eur Rev Med Pharmacol Sci. 2019. PMID: 31364115
-
Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.Int J Biol Macromol. 2018 Feb;107(Pt B):2620-2629. doi: 10.1016/j.ijbiomac.2017.10.154. Epub 2017 Oct 26. Int J Biol Macromol. 2018. PMID: 29080815
-
LncRNAs orchestration of gastric cancer - particular emphasis on the etiology, diagnosis, and treatment resistance.Funct Integr Genomics. 2024 Sep 26;24(5):175. doi: 10.1007/s10142-024-01450-8. Funct Integr Genomics. 2024. PMID: 39325107
-
The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231206003. doi: 10.1177/15330338231206003. Technol Cancer Res Treat. 2023. PMID: 37849311 Free PMC article. Review.
Cited by
-
MiRNAs: main players of cancer drug resistance target ABC transporters.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):6239-6291. doi: 10.1007/s00210-024-03719-y. Epub 2025 Jan 14. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39808313 Review.
-
New insights into the interaction between m6A modification and lncRNA in cancer drug resistance.Cell Prolif. 2024 Apr;57(4):e13578. doi: 10.1111/cpr.13578. Epub 2023 Nov 14. Cell Prolif. 2024. PMID: 37961996 Free PMC article. Review.
-
Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications.Biomolecules. 2024 May 22;14(6):608. doi: 10.3390/biom14060608. Biomolecules. 2024. PMID: 38927012 Free PMC article. Review.
-
Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation.PLoS One. 2024 Oct 14;19(10):e0311680. doi: 10.1371/journal.pone.0311680. eCollection 2024. PLoS One. 2024. PMID: 39401197 Free PMC article.
-
LncRNA in gastric cancer drug resistance: deciphering the therapeutic strategies.Front Oncol. 2025 Apr 1;15:1552773. doi: 10.3389/fonc.2025.1552773. eCollection 2025. Front Oncol. 2025. PMID: 40236651 Free PMC article. Review.
References
-
- Yu T, An Q, Cao XL, et al. GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway. Life Sci. 2020;260:1‐12. - PubMed
-
- Wang Y, Wang Y, Qin Z, et al. The role of non‐coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Expert Opin Drug Metab Toxicol. 2021;17(3):291‐306. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 2020YJ0379/The Sichuan Provincial Department of Science and Technology
- 20SXJCQN0004;20SXQT0053;18SXHZ0281/The Special Foundation of Cooperation between Nanchong Government and North Sichuan Medical College
- 2020AD30058/The Science and Technology Project of Jiaxing City
- 2023-ZC-002/Jiaxing Key Discipiline of Medcine -Clinical diagnostics
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous